PSI CRO AG
PSI CRO AG is a privately held, globally operating full-service contract research organization delivering pivotal Phase 2/3 clinical trials across 58 countries for pharmaceutical and biotech sponsors, supported by its proprietary INTELIA™ AI-powered platform suite.
- Company typePrivate
- Founded1995
- HeadquartersZug, Switzerland
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What PSI CRO AG does
PSI CRO AG is a global full-service contract research organization (CRO) founded in 1995 and headquartered in Zug, Switzerland. The company provides end-to-end clinical development services — including protocol design, site management, data management, biostatistics, regulatory affairs, medical monitoring, and pharmacovigilance — to pharmaceutical and biotechnology sponsors, with documented specializations across oncology, gastroenterology, hematology, cell and gene therapy, neurology, infectious diseases, radiopharmaceuticals, and respiratory therapeutics. Its customer base includes Top 20 global pharmaceutical companies and clinical-stage biotech sponsors such as Melinta Therapeutics and Atossa Therapeutics.
The company's core differentiator is the proprietary INTELIA™ platform, which integrates six operational modules: SYNETIC™ (AI-powered semantic knowledge platform for site intelligence, launched January 2026 and built on data from 500,000+ institutions and 3 million study sites); VISIONAL™ (clinical and financial feasibility modeling with GenAI); CLARITY™ (budgeting); CADENCE™ (budget tracking); INSITE™ (investigator grant calculation); and PACE™ (risk-based monitoring). SYNETIC™ employs agentic AI, NLP, knowledge graphs, and multimodal semantic data platforms (OmniRAG architecture) for predictive site selection. PSI CRO AG operates across 58 countries with 3,200+ professionals and reports on-time delivery above 90% on its projects.
PSI CRO AG generates revenue through professional-services contracts with pharmaceutical and biotech sponsors on a quote-based, project-specific model. Pricing is not publicly disclosed and is tailored to study complexity, therapeutic area, and geographic scope. The company employs a direct enterprise field sales motion, with RFP-driven engagement and no third-party distribution. PSI CRO AG is privately held by its founding management group — described in the input as the only fully independent and privately owned global mid-sized CRO — with no disclosed external funding rounds, parent company, or institutional investors.
PSI CRO AG firmographics
Firmographics- Name
- PSI CRO AG
- Legal name
- PSI CRO AG
- Website
- https://psi-cro.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- PSI CRO AG is a privately held, globally operating full-service contract research organization delivering pivotal Phase 2/3 clinical trials across 58 countries for pharmaceutical and biotech sponsors, supported by its proprietary INTELIA™ AI-powered platform suite.
- Ownership category
- akta.pro rank
PSI CRO AG industry classification
Industry- Product category
- Contract Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
Keywords
Where PSI CRO AG is headquartered
LocationHeadquarters
- HQ city
- Zug
- HQ country
- Switzerland
- HQ region
- Europe
Offices24 records
Markets served
PSI CRO AG business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: PSI CRO AG generates revenue through project-based professional services contracts with pharmaceutical and biotech sponsors, providing full-service CRO services across clinical development. Contracts are typically long-term, multi-study engagements with defined project milestones and deliverables.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
PSI CRO AG product offering
Product offeringCore offering
PSI CRO AG is a global full-service Contract Research Organization (CRO) that delivers pivotal Phase II–III clinical trials on time for pharmaceutical and biotech sponsors across eight therapeutic areas: oncology, gastroenterology, hematology, cell and gene therapy, neurology, infectious diseases, radiopharmaceuticals, and respiratory. Operations span 58 countries with 3,200+ professionals and 10,000+ investigator sites, supported by the proprietary INTELIA™ AI-powered technology platform suite (SYNETIC™, VISIONAL™, CLARITY™, CADENCE™, INSITE™, PACE™).
Product overview
PSI CRO AG is a global full-service contract research organization (CRO) that operates as a single unified offering with proprietary technology platforms. The core service is the delivery of pivotal Phase 2/3 clinical trials on-time, supported by the INTELIA™ technology platform comprising six integrated modules: SYNETIC™ (AI-powered site intelligence), VISIONAL™ (clinical/financial feasibility), CLARITY™ (budgeting), CADENCE™ (budget tracking), INSITE™ (investigator grants), and PACE™ (monitoring planning). CRO services span oncology, gastroenterology, hematology, cell and gene therapy, neurology, infectious diseases, radiopharmaceuticals, and respiratory therapeutics across 58 countries.
Differentiator
Problem solved
Functional benefit
Brands
- SYNETIC™: AI-powered semantic knowledge platform for clinical trial site intelligence, selection, and startup acceleration
- VISIONAL™
- INTELIA™
- CLARITY™
- CADENCE™
- INSITE™
- PACE™
Products and services
- INTELIA™ Clinical Trial Intelligence Platform Integrated AI-powered clinical trial intelligence platform suite combining SYNETIC™, VISIONAL™, CLARITY™, CADENCE™, INSITE™, and PACE™ modules to optimize trial planning, feasibility, budgeting, tracking, site grants, and monitoring for pharmaceutical and biotech sponsors.
- SYNETIC™ AI-Powered Semantic Site Intelligence Platform Standalone AI-powered semantic knowledge platform for clinical trial site intelligence, selection, and startup acceleration, built on data from 500,000+ institutions, 3 million study sites, and 300,000 clinical projects with agentic AI, NLP, knowledge graphs, and predictive analytics.
- VISIONAL™ Clinical and Financial Feasibility Platform AI/ML-driven platform combining clinical and financial feasibility to model and compare hundreds of enrollment scenarios, budgets, and probability of success for protocols and portfolios, with live budget simulations.
- Oncology CRO Services Full-service oncology clinical research organization support for pivotal Phase 2/3 trials, including 60 board-certified oncologists, expertise in radiopharmaceuticals, ADCs, and cell therapies, and access to 10,000 sites in 62 countries.
- Gastroenterology (GI) CRO Services Specialized GI and IBD clinical trial services with 6,000 GI sites in 60 countries, 50%+ higher enrollment rates, in-house board-certified gastroenterologists, and expertise in complex combination and platform studies.
- Hematology CRO Services Hematology and hematology-oncology clinical trial services with 4,200 hematology sites in 60 countries, 93% on-time enrollment rate, 14 drug approvals including one of the first gene therapies, and 10 in-house hematologists.
- Cell and Gene Therapy CRO Services Advanced therapy clinical trial support with 20 years of CGT experience, expertise across CAR-T, gene editing, and stem cell therapy, involvement in key industry approvals, and specialized site support including cell therapy nurses and technology specialists.
- Neurology CRO Services CNS and neuroscience clinical trial services with 10 CNS drug approvals, 75% of MS drug approvals in the past 5 years, 20+ years of CNS experience, expertise in adult and pediatric populations, and dedicated support for emerging technologies including neuroimaging.
- Infectious Diseases CRO Services Infectious disease clinical trial services having delivered 50% of antibiotics to market since 2010, with 14 drug approvals, 28,000 patients enrolled across 45 countries, and ID-focused laboratory support services.
- Radiopharmaceuticals CRO Services Leading radiopharmaceutical clinical trial services with #1 industry theranostic approval, 40% of pivotal RLT studies, 1,000+ qualified RLT sites, and a dedicated radiopharmaceutical strategy team including nuclear medicine, imaging, dosimetry, and nuclear pharmacy experts.
- Respiratory CRO Services Respiratory and pulmonary clinical trial services with 6 drug approvals, 10,000+ patients enrolled, 50+ late-stage respiratory studies, and expertise in COPD, IPF, asthma, pneumonia, and specialized spirometry standardization.
Quantifiable outcome
- 90%+ of projects delivered on schedule
Companies that use PSI CRO AG
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles1 record
PSI CRO AG technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature7 records
PSI CRO AG partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- SanoficorePSI CRO AG discussed site ID collaboration with Sanofi at SCOPE 2026, indicating a co-development partnership for clinical site identification and activation services.
- University of MissouricorePSI CRO AG collaborates with the University of Missouri on radiopharmaceutical clinical research, leveraging academic expertise and patient populations for specialized oncology studies.
- XcancercorePSI CRO AG partners with Xcancer in the field of radiopharmaceuticals, combining Xcancer's specialized oncology expertise with PSI CRO AG's global operational capabilities for clinical development.
- ITM Isotope Technologies Munich SEcorePSI CRO AG utilizes its VISIONAL platform in collaboration with ITM Isotope Technologies Munich SE for clinical and financial feasibility assessment in radiopharmaceutical studies, integrating PSI CRO AG's technology with ITM's isotope expertise.
Scale indicators4 records
Recent moves10 records
Expansion highlights5 records
PSI CRO AG competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
PSI CRO AG social profiles
Digital presencePSI CRO AG financial estimates
Financial estimateRevenue estimate
Valuation estimate
PSI CRO AG leadership team
Management profileNumber of profiles
Profiles10 records
PSI CRO AG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PSI CRO AG M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PSI CRO AG
What does PSI CRO AG do?
PSI CRO AG is a global full-service Contract Research Organization (CRO) that delivers pivotal Phase II–III clinical trials on time for pharmaceutical and biotech sponsors across eight therapeutic areas: oncology, gastroenterology, hematology, cell and gene therapy, neurology, infectious diseases, radiopharmaceuticals, and respiratory. Operations span 58 countries with 3,200+ professionals and 10,000+ investigator sites, supported by the proprietary INTELIA™ AI-powered technology platform suite (SYNETIC™, VISIONAL™, CLARITY™, CADENCE™, INSITE™, PACE™).
Is PSI CRO AG a public or private company?
PSI CRO AG is a private company. It is classified as management employee owned and is currently operating.
When was PSI CRO AG founded?
PSI CRO AG was founded in 1995. It employs 1,001 to 5,000 people.
Where is PSI CRO AG based?
PSI CRO AG is headquartered in Zug, Switzerland, in the Europe region.
How does PSI CRO AG make money?
One revenue line is on record: clinical Research Services.
Does PSI CRO AG have an API?
No public API is recorded for PSI CRO AG.
What industry is PSI CRO AG in?
PSI CRO AG's product category is Contract Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.